mobile.zenopa.com Homepage Homepage
Employment Role Location
Business Sector Advanced
Phone 01494 818 000

View company profile
Current Jobs

Regional Account Manager
Location: South East (including London)

Healthcare Policy Manager
Location: London North

Clinical Development Advisor
Location: Surrey

Novartis to acquire majority share of Alcon

Posted on 04/01/2010 in Pharmaceutical Company Restructures

Novartis has welcomed the new year with the announcement that it plans to buy the majority share of its fellow pharmaceutical firm Alcon.

In a bid to strengthen the company's presence in the eye care market, it plans to gain full ownership of Alcon, with the first step of the transaction being the completion of a deal with Nestle SA to acquire a 77 per cent majority stake in the organisation.

Alcon will retain the remaining 23 per cent minority stake.

Dr Daniel Vasella, chairman and chief executive officer of Novartis, commented: "The addition of Alcon will strategically strengthen our healthcare portfolio and our position in eye care, a sector with dynamic growth due to the increasing patient needs of an ageing population."

In other Novartis news, the firm announced last month that it plans to acquire Corthera - a move that will result in its gaining of the rights to the cardiovascular morbidity reduction drug relaxin.

Other news stories from 04/01/2010

Read more in the Zenopa News Archive

How this news is generated

James
Account Manager
for this opportunity

01494 818 002
(Mon to Fri 0830 to 1800 hours)
jamesh@zenopa.com

Latest News

Novartis to get priority review for multiple sclerosis drug

Novartis receives FDA approval for meningococcal disease vaccine

Novartis leukaemia drug to get priority FDA review

Novartis acquires exclusive rights to Debio 025

Novartis announces financial results for 2009

home | our clients | browse news | browse jobs | links | hotel directory | Valid HTML | copyright © 2010 Zenopa Ltd | terms & conditions of use